CD4 and infection: As the dual-tropic R3A can also utilize CXCR4 for infection, we found R3A replication in CD4 T cells wasn’t significantly affected by TAK-779 treatment, as measured by intracellular p24 staining or extracellular HIV-1 RT levels (Fig. 2a).